Amalgamated Financial (AMAL) Research & Development (2020 - 2026)

Amalgamated Financial has reported Research & Development for 7 years, with the latest figure at $7.4 million in Q2 2026.

• On a quarterly basis, Research & Development rose 35.13% year-over-year to $7.4 million in Q2 2026; TTM through Jun 2026 was $27.0 million, a 25.65% increase from a year earlier, with the FY2025 full-year figure at $24.1 million, up 21.58% from the prior year.
• Research & Development was $7.4 million for Q2 2026 at Amalgamated Financial, up from $6.6 million in the prior quarter.
• The five-year high for Research & Development was $7.4 million in Q2 2026, with the low at $4.1 million in Q4 2022.
• Average Research & Development over 5 years is $5.2 million, with a median of $4.9 million recorded in 2024.
• The largest YoY upside for Research & Development was 72.51% in 2022 against a maximum downside of 21.6% in 2022.
• Over 5 years, Research & Development stood at $4.1 million in 2022, then gained by 12.18% to $4.6 million in 2023, then advanced by 16.0% to $5.3 million in 2024, then soared by 31.93% to $7.0 million in 2025, then rose by 6.02% to $7.4 million in 2026.
• The last three Research & Development figures came in at $7.4 million (Q2 2026), $6.6 million (Q1 2026), and $7.0 million (Q4 2025), per Business Quant data.